Coloplast A/S (OTCMKTS:CLPBY) Sets New 12-Month Low – Here’s What Happened

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) shares reached a new 52-week low during trading on Tuesday . The stock traded as low as $5.65 and last traded at $5.65, with a volume of 6866 shares traded. The stock had previously closed at $5.78.

Analysts Set New Price Targets

Several brokerages have weighed in on CLPBY. The Goldman Sachs Group cut Coloplast A/S from a “hold” rating to a “strong sell” rating in a research note on Tuesday, April 7th. Kepler Capital Markets raised Coloplast A/S to a “strong-buy” rating in a research note on Wednesday, May 20th. One analyst has rated the stock with a Strong Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Coloplast A/S has an average rating of “Hold”.

Coloplast A/S Stock Performance

The company has a current ratio of 1.75, a quick ratio of 1.09 and a debt-to-equity ratio of 1.66. The business’s 50 day moving average is $6.17 and its 200 day moving average is $7.23. The stock has a market capitalization of $12.76 billion, a PE ratio of 40.43, a PEG ratio of 1.87 and a beta of 0.18.

Coloplast A/S (OTCMKTS:CLPBY) last issued its quarterly earnings results on Tuesday, May 12th. The company reported $0.10 EPS for the quarter, beating the consensus estimate of $0.09 by $0.01. Coloplast A/S had a net margin of 7.46% and a return on equity of 33.15%. The company had revenue of $1.11 billion for the quarter, compared to the consensus estimate of $1.11 billion. On average, equities research analysts predict that Coloplast A/S Sponsored ADR will post 0.4 earnings per share for the current fiscal year.

Coloplast A/S Company Profile

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.